When she was 12, doctors determined that Misty’s blindness had a genetic cause called Leber ... and they could read more lines on an eye chart. One Saturday at home, Bennett was looking at ...

Qfitlia is indicated in the U.S. for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or B ...

Plans and pricing Video Back ...

Hemophilia is a rare but serious inherited disease. The constant risk of unexpected bleeding makes it a silent and persistent ...

Hemophilia represents a rare, lifelong bleeding disorder characterized by the blood's inability to clot normally. While management strategies have advanced ...

Hemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX), respectively. Patients with these hemophilias are ...

Hemophilia is a rare bleeding disorder where the blood doesn’t clot the way it should, making even minor injuries potentially serious. According to the Centers for Disease Control and Prevention ...

Fitusiran is an anti-thrombin-directed small interfering ribonucleic acid therapeutic that prevents bleeds in patients with hemophilia A or B by reducing antithrombin levels. The efficacy and ...

Hemophilia A and B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX), respectively. Qfitlia does not replace the missing clotting ...

Opens in a new tab or window The FDA approved fitusiran (Qfitlia) as prophylaxis to prevent or reduce bleeding episodes in adults and children ages 12 years and up with hemophilia A or B ...

Hemophilia is an inherited illness that is characterised by its inability to make the blood clot, causing uncontrollable ...